Fred Telling, Director at ORAGENICS INC (OGEN), bought 27,000 shares at $0.95 ($26K) on 2014-11-14, disclosed to the SEC on 2014-11-17.
Open-market purchase of $26k OGEN by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.91 | 100 | $91 | 0.4% |
| 2 | $0.91 | 2,400 | $2K | 8.5% |
| 3 | $0.95 | 100 | $95 | 0.4% |
| 4 | $0.95 | 4,302 | $4K | 16.0% |
| 5 | $0.95 | 20,098 | $19K | 74.7% |
| Total | $0.95 avg | 27,000 |
| $26K |
| 100% |
| Filing → |
| OGEN | SELL | 2024-12-09 | $1K | — | Filing → |
| OGEN | SELL | 2023-12-01 | $12K | — | Filing → |
| OGEN | BUY | 2022-06-21 | $3K | — | Filing → |